NDC 81033-412-15 - Potassium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-412
- Requested NDC
- 81033-412-15
- Package NDCs from labels
- 81033-412-15, 81033-412-51, 81033-412-50, 81033-412-30, 81033-412-32, 81033-412-34
- Manufacturer
- Kesin Pharma
- Effective date
- 2024-12-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Potassium Chloride - Kesin Pharma | Kesin Pharma | 2024-12-04 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-412-15 | Potassium Chloride | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 5 | |
| 81033-412-30 | Potassium Chloride | 30 mL in 1 CUP, UNIT-DOSE | SOLUTION | 30 | 5 | |
| 81033-412-32 | Potassium Chloride | 100 in 1 CASE | SOLUTION | 100 | 5 | |
| 81033-412-34 | Potassium Chloride | 50 in 1 CASE | SOLUTION | 50 | 5 | |
| 81033-412-50 | Potassium Chloride | 100 in 1 CASE | SOLUTION | 100 | 5 | |
| 81033-412-51 | Potassium Chloride | 50 in 1 CASE | SOLUTION | 50 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-412-15 | ML - Milliliter | 81033-412 | bbfbf218-c6fa-4f1f-a0b0-fd6c48577135 | 1 | 2024-08-12 |
| 81033-412-30 | ML - Milliliter | 81033-412 | b5400981-8240-485c-9d9f-87593850377e | 1 | 2024-08-12 |
| 81033-412-32 | ML - Milliliter | 81033-412 | 1d5cbd7d-98e5-4435-a285-be3bbff8b14a | 1 | 2024-08-12 |
| 81033-412-34 | ML - Milliliter | 81033-412 | ee33d2e1-7700-4f90-a7b5-9808c406891d | 1 | 2024-09-09 |
| 81033-412-50 | ML - Milliliter | 81033-412 | 3ec55d88-9e5c-430c-a4e9-fd74b75400de | 1 | 2024-08-12 |
| 81033-412-51 | ML - Milliliter | 81033-412 | a4c9fc82-8b5d-4db7-8def-ac8c2c3d5a44 | 1 | 2024-08-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 0e875691-7372-46ac-80a1-946e08b40061 | 2025-09-30 | Warnings, Adverse reactions | 660YQ98I10 |
| Xpect Eyewash | EYEWASH | Cintas Corporation | 1d69365d-662b-4248-8fa9-1629451b549a | 2025-09-30 | Warnings | 059QF0KO0R |
| CheBoho TEA TREE ACNE | CHEBOHO TEA TREE ACNE | Opalshi(Guangzhou)E-commerce Co. Ltd. | 3fc4cf84-b2da-c593-e063-6394a90abc5c | 2025-09-27 | Warnings | 059QF0KO0R |
| Hemorrhoidal Pain Relief | HEMORRHOIDAL PAIN RELIEF CREAM | Neilmed Pharmaceuticals Inc. | 374dc1c0-4243-b272-e063-6394a90a5a6b | 2025-09-24 | Warnings | PDC6A3C0OX |
| Potassium Chloride | POTASSIUM CHLORIDE | Epic Pharma, LLC | 00615fad-ad3b-46e8-a89d-48290d937ae2 | 2025-09-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Macleods Pharmaceuticals Limited | 89d827c8-91af-4bfd-a846-62e55824e983 | 2025-09-22 | Warnings, Adverse reactions | 314182 312515 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | a9d68a40-75e3-4c5c-b5d7-1d6160527fa7 | 2025-09-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Sterile Water | WATER | ProPharma Distribution | 3f2ae880-852f-b45d-e063-6394a90aa1cc | 2025-09-19 | Warnings, Adverse reactions | 059QF0KO0R |
| Potassium Chloride | POTASSIUM CHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 542e16b0-44db-490f-b44e-4c88a6e3d8b8 | 2025-09-17 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Strides Pharma Science Limited | 0224e5b3-3c49-4e6e-aa78-1abcc6969246 | 2025-09-17 | Warnings, Adverse reactions | 660YQ98I10 |
| Perikabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | c2eb5522-8572-45f4-869d-42f9fd251bb6 | 2025-09-15 | Warnings, Adverse reactions | 660YQ98I10 |
| REFRESH OPTIVE Drops | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 80275190-d717-40ea-905b-5c8fbe986eac | 2025-09-15 | Warnings | PDC6A3C0OX |
| Refresh Relieva PF Xtra | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | b51b8a75-8faa-430f-8f7e-ee58d3d13f2e | 2025-09-15 | Warnings | PDC6A3C0OX |
| Refresh Relieva | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 6b984fa2-4187-45ef-b7d3-15e720abc667 | 2025-09-15 | Warnings | PDC6A3C0OX |
| Dry eye relief | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | CARDINAL HEALTH 110, LLC. DBA LEADER | f8da3af5-9172-4023-be82-0fd5bd891616 | 2025-09-12 | Warnings | 6DC9Q167V3 |
| Oasis Tears PF Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | 640f95f4-c2e8-48ad-ad40-f76bbaddb0dc | 2025-09-12 | Warnings | PDC6A3C0OX |
| Kabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | afeb4837-a759-4484-a76e-e04611c459e7 | 2025-09-11 | Warnings, Adverse reactions | 660YQ98I10 |
| GAVILYTE-N | POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE | Lupin Pharmaceuticals,Inc. | 27195187-75a3-431f-90d9-84da1b94e849 | 2025-09-10 | Warnings, Adverse reactions | 660YQ98I10 |
| GAVILYTE G TM | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Lupin Pharmaceuticals,Inc. | 3978822b-6473-4072-9f80-20ceb9bea355 | 2025-09-10 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Preferred Pharmaceuticals Inc. | 87f369cf-40e5-4f91-aa42-ae986fce6544 | 2025-09-10 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.